Randomized, Double-Blind, Placebo-Controlled Study of Efficacy and Safety of Donepezil Hydrochloride in Preadolescent and Adolescent Children With Attention Impairment Following Cancer Treatment.
Phase of Trial: Phase III
Latest Information Update: 03 Jul 2012
At a glance
- Drugs Donepezil (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- Sponsors Eisai Inc; Eisai Medical Research
- 25 Sep 2009 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.
- 25 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 May 2009 Additional locations reported by ClinicalTrials.gov.